Skip to content

Florida · Nonprofit

Society of Neuroimmune Pharmacology Inc

Society of Neuroimmune Pharmacology Inc (Florida) receives grants from 1 organization whose IRS filings report $28,000 to it, the largest being SETON HALL UNIVERSITY ($28,000). 0 of them have funded it in more than one year.

Revenue FY2025
$76k
Funders on record
1
Grants received
$28k
Net assets
$68k
0/1 repeat funderspeak grant-dependency 46%
01What it does

What Society of Neuroimmune Pharmacology Inc does

Mission

The mission of the SNIP is to: promote research and serve as a reliable source of information in the pharmacology, immunology, and neuroscience of the neuroimmune axis; foster exchange of information and ideas on neuroimmune pharmacology by holding an annual SNIP Conference, maintaining a Society web site (s-nip.org), and supporting and promoting the Society journal, the Journal of Neuroimmune Pharmacology (JNIP); encourage financial support from funding agencies, industry, and the SNIP membership to effect the SNIP mission.

As stated on its FY2025 Form 990-EZ.

Program

  1. The society sponsored a conference for attendees to present scientific research which includes new data, trends in the field and novel technology related to the area of Neuroimmune Pharmacology. The conference was attended by approximately 210 scientists of all career stages (students, staff, and professors). The society sponsors students and post-doctoral fellows to attend the annual conference.

    $0 spent

The program described on its FY2025 Form 990-EZ.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($155k) Expenses 100 ($176k) Net assets 100 ($181k)2018 Revenue 56 ($87k) Expenses 111 ($195k) Net assets 40 ($73k)2019 Revenue 163 ($252k) Expenses 105 ($184k) Net assets 78 ($141k)2020 Revenue 22 ($33k) Expenses 22 ($39k) Net assets 75 ($135k)2022 Revenue 59 ($92k) Expenses 22 ($38k) Net assets 102 ($184k)2023 Revenue 40 ($61k) Expenses 77 ($136k) Net assets 61 ($110k)2024 Revenue 74 ($114k) Expenses 59 ($103k) Net assets 66 ($120k)2025 Revenue 49 ($76k) Expenses 73 ($128k) Net assets 37 ($68k)
'17'18'19'20'22'23'24'25
Revenue (49)Expenses (73)Net assets (37)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2017 to 2018, from $181k to $73k (−60%).

$181k
$73k
$141k
$135k
$184k
$110k
$120k
$68k
'17'18'19'20'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

7% of Society of Neuroimmune Pharmacology Inc’s revenue is contributions — more earned-revenue than three-quarters of its peers (100% for the typical peer).

This organization
Typical peer · 12,214 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 5 of the last 8 reported years ran a deficit.

−$21k
’17
−$108k
’18
$68k
’19
−$5k
’20
$53k
’22
−$75k
’23
$11k
’24
−$52k
’25
9.2
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Sabita Roy

Meeting Chair (Thru 6/25)

As listed on its FY2025 Form 990-EZ.

03Who funds it

Who funds it, year by year

Grant support over time, funder by funder — shade shows the grant size each year.

Funder
'23
total
$28k
funders
1

From the IRS filings of Society of Neuroimmune Pharmacology Inc’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

Society of Neuroimmune Pharmacology Inc draws 100% of its grant income from funders outside Florida, across 1 state in all.

NJ

Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

Society of Neuroimmune Pharmacology Inc's revenue fell 51% between 2017 and 2025.

Operating margin−69% · bottom quartile
Revenue growth (annualized)−9% · below the median

this organization peer median middle 50% of peers· 6,360 health nonprofits under $100k, FY2025

Government funding Society of Neuroimmune Pharmacology Inc receives

Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $35k on record.

Federal$35k
grants $35kcontracts $0
25
26
Top agencies
  • Department of Health and Human Services$35k

Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.

Organizations like Society of Neuroimmune Pharmacology Inc

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Florida

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Public support

85%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Screen this organization

A dated, signed PDF of the compliance screen for Society of Neuroimmune Pharmacology Inc: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds Society of Neuroimmune Pharmacology Inc?
Society of Neuroimmune Pharmacology Inc (Florida) receives grants from 1 organization whose IRS filings report $28,000 to it, the largest being SETON HALL UNIVERSITY ($28,000). 0 of them have funded it in more than one year.
How many funders does Society of Neuroimmune Pharmacology Inc have?
IRS filings report 1 organization giving $28,000 in grants to Society of Neuroimmune Pharmacology Inc.
Who is the largest funder of Society of Neuroimmune Pharmacology Inc?
SETON HALL UNIVERSITY is the largest funder on record, with $28,000 in grants. The full list of funders is on this page.
How can an organization like Society of Neuroimmune Pharmacology Inc find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Florida. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Society of Neuroimmune Pharmacology →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing